Page 248 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 248
Viral Hepatitis: Hepatitis C - Clinical (Except Therapy) (Cont.)
P0739 IMPACT OF SERUM APOLIPOPROTEIN PROFILES IN
CHRONIC HCV INFECTION: DIFFERENCE BETWEEN HCV
GENOTYPES 1B AND 2
Nobuyoshi Seki*, Tomohisa Nagano, Tomonori Sugita,Yuta Aida,
Hiroshi Abe,Yoshio Aizawa, Japan
P0740 USEFULNESS OF INTERFERON LAMBDA4-, HLA CLASS
II-POLYMORPHISM AND KILLER-IMMUNGLOBULIN-LIKE
RECEPTOR-2DL3:C1/C1 TO PREDICT SPONTANEOUS
CLEARANCE OF ACUTE HEPATITIS C VIRUS INFECTION
Sandra Beinhardt*, Mattias Mandorfer, Berit A. Payer,
Albert F. Stättermayer, Christian Datz, Andreas Maieron,
Florian Huber, Emina Dulic-Lakovic, Rudolf Stauber, Gottfried Fischer,
Michael Gschwantler, Peter Ferenci, Harald Hofer, Austria
P0741 IMPACT OF PILL COUNT ON MEDICATION ADHERENCE
DURING THE FIRST 12 WEEKS OF HIV ANTIVIRAL
ePOSTERS TREATMENT: IMPLICATIONS FOR HCV TREATMENT
Timothy R. Juday*, Robert W. Baran, Shivaji R. Manthena,
David R. Walker, The United States
P0742 HEPATITIS C TESTING IN PEOPLE ATTENDING AN
INNER CITY DRUG MISUSE CENTRE – ARE SCREENING
GUIDELINES ADHERED TO?
Victoria Appleby*, Elizabeth Darnbrough, Kelly Forrester,
Charlotte Clarke, Rhian Simpson, Sulleman Moreea, The United Kingdom
P0743 INTERLEUKIN-6 IS ASSOCIATED WITH LIVER FIBROSIS IN
HCV-INFECTED PATIENTS WITH ALCOHOL ABUSE
Luciana D. Silva*,Yala G. G. Giampietro, Barbara D. M. Theobaldo,
Luciana R. da Cunha, Rosangela Teixeira, Gifone A. Rocha,
Dulciene M. D. M. Queiroz, Olindo A. Martins Filho,
Fernando S. Neves, Brazil
P0744 PREVALENCE OF CO-MORBIDITIES BY HEPATITIS C VIRUS
STATUS IN THE U.S. POPULATION
Mariana Lazo*, Natalie Daya, Chizoba Nwankwo, Kerry Willis,
Morgan Grams, Elizabeth Selvin, The United States
248 The International Liver Congress™ 2015 • ILC Programme
P0739 IMPACT OF SERUM APOLIPOPROTEIN PROFILES IN
CHRONIC HCV INFECTION: DIFFERENCE BETWEEN HCV
GENOTYPES 1B AND 2
Nobuyoshi Seki*, Tomohisa Nagano, Tomonori Sugita,Yuta Aida,
Hiroshi Abe,Yoshio Aizawa, Japan
P0740 USEFULNESS OF INTERFERON LAMBDA4-, HLA CLASS
II-POLYMORPHISM AND KILLER-IMMUNGLOBULIN-LIKE
RECEPTOR-2DL3:C1/C1 TO PREDICT SPONTANEOUS
CLEARANCE OF ACUTE HEPATITIS C VIRUS INFECTION
Sandra Beinhardt*, Mattias Mandorfer, Berit A. Payer,
Albert F. Stättermayer, Christian Datz, Andreas Maieron,
Florian Huber, Emina Dulic-Lakovic, Rudolf Stauber, Gottfried Fischer,
Michael Gschwantler, Peter Ferenci, Harald Hofer, Austria
P0741 IMPACT OF PILL COUNT ON MEDICATION ADHERENCE
DURING THE FIRST 12 WEEKS OF HIV ANTIVIRAL
ePOSTERS TREATMENT: IMPLICATIONS FOR HCV TREATMENT
Timothy R. Juday*, Robert W. Baran, Shivaji R. Manthena,
David R. Walker, The United States
P0742 HEPATITIS C TESTING IN PEOPLE ATTENDING AN
INNER CITY DRUG MISUSE CENTRE – ARE SCREENING
GUIDELINES ADHERED TO?
Victoria Appleby*, Elizabeth Darnbrough, Kelly Forrester,
Charlotte Clarke, Rhian Simpson, Sulleman Moreea, The United Kingdom
P0743 INTERLEUKIN-6 IS ASSOCIATED WITH LIVER FIBROSIS IN
HCV-INFECTED PATIENTS WITH ALCOHOL ABUSE
Luciana D. Silva*,Yala G. G. Giampietro, Barbara D. M. Theobaldo,
Luciana R. da Cunha, Rosangela Teixeira, Gifone A. Rocha,
Dulciene M. D. M. Queiroz, Olindo A. Martins Filho,
Fernando S. Neves, Brazil
P0744 PREVALENCE OF CO-MORBIDITIES BY HEPATITIS C VIRUS
STATUS IN THE U.S. POPULATION
Mariana Lazo*, Natalie Daya, Chizoba Nwankwo, Kerry Willis,
Morgan Grams, Elizabeth Selvin, The United States
248 The International Liver Congress™ 2015 • ILC Programme
